Clinical Trial: Blood Based Risk Evaluation With AI for Targeted Primary Health Care in Early Lung Cancer Detection

U.S., April 28 -- ClinicalTrials.gov registry received information related to the study (NCT07552584) titled 'Blood Based Risk Evaluation With AI for Targeted Primary Health Care in Early Lung Cancer Detection' on April 20.

Brief Summary: The study is a prospective, non-randomized feasibility study evaluating blood sample and machine learning-based risk stratification for lung cancer in patients with COPD (chronic obstructive pulmonary disease).

Patients with COPD will be recruited in general practice, where they will have a blood sample drawn. All data will be analyzed by the machine learning model, and patients with increased risk of lung cancer will be referred for a low-dose CT scan of the chest.

The primary objective of the study is...